These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10435212)

  • 1. A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism.
    Schmider J; Standhart H; Deuschle M; Drancoli J; Heuser I
    Biol Psychiatry; 1999 Aug; 46(3):437-41. PubMed ID: 10435212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepines for catatonic symptoms, stupor, and mutism.
    Wetzel H; Heuser I; Benkert O
    Pharmacopsychiatry; 1988 Nov; 21(6):394-5. PubMed ID: 2907648
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and side effects of lorazepam, oxazepam, and temazepam as sleeping aids in psychogeriatric inpatients.
    Linnoila M; Viukari M; Lamminsivu U; Auvinen J
    Int Pharmacopsychiatry; 1980; 15(2):129-35. PubMed ID: 6108299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of additional oxazepam in long-term users of oxazepam.
    Voshaar RC; Verkes RJ; van Luijtelaar GL; Edelbroek PM; Zitman FG
    J Clin Psychopharmacol; 2005 Feb; 25(1):42-50. PubMed ID: 15643099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of clobazam and lorazepam on the psychomotor performance of anxious patients.
    Oblowitz H; Robins AH
    Br J Clin Pharmacol; 1983 Jul; 16(1):95-9. PubMed ID: 6136292
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypnotic efficacy and safety of midazolam and oxazepam in hospitalized female patients.
    Fischbach R
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):157S-160S. PubMed ID: 6138070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study.
    Ungvari GS; Chiu HF; Chow LY; Lau BS; Tang WK
    Psychopharmacology (Berl); 1999 Mar; 142(4):393-8. PubMed ID: 10229064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lorazepam and oxazepam on perceptual and procedural memory functions.
    Martin J; Matthews A; Martin F; Kirkby KC; Alexander J; Daniels B
    Psychopharmacology (Berl); 2002 Nov; 164(3):262-7. PubMed ID: 12424549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam.
    Rosebush PI; Hildebrand AM; Furlong BG; Mazurek MF
    J Clin Psychiatry; 1990 Sep; 51(9):357-62. PubMed ID: 2211547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of catatonia-like signs by lorazepam in nonconvulsive status epilepticus without seizure termination.
    Swartz CM; Bottum KM; Salazar Jr LS
    Am J Geriatr Psychiatry; 2002; 10(3):348-50. PubMed ID: 11994224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catatonic mutism after liver transplant rapidly reversed with lorazepam.
    O'Donnell MM; Williams JP; Weinrieb R; Denysenko L
    Gen Hosp Psychiatry; 2007; 29(3):280-1. PubMed ID: 17484951
    [No Abstract]   [Full Text] [Related]  

  • 12. [Benzodiazepines in the treatment of catatonia].
    Van Dalfsen AN; Van Den Eede F; Van Den Bossche B; Sabbe BG
    Tijdschr Psychiatr; 2006; 48(3):235-9. PubMed ID: 16956088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind placebo cross-over study of long-acting (chlordesmethyldiazepam) versus short-acting (lorazepam) benzodiazepines in generalized anxiety disorders.
    Bertin I; Colombo G; Furlanut M; Benetello P
    Int J Clin Pharmacol Res; 1989; 9(3):203-8. PubMed ID: 2568350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia.
    Northoff G; Pfennig A; Krug M; Danos P; Leschinger A; Schwarz A; Bogerts B
    Schizophr Res; 2000 Sep; 44(3):193-211. PubMed ID: 10962222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse performance effects of acute lorazepam administration in elderly long-term users: pharmacokinetic and clinical predictors.
    Pomara N; Lee SH; Bruno D; Silber T; Greenblatt DJ; Petkova E; Sidtis JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():129-35. PubMed ID: 25195839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
    Woelk H; Schläfke S
    Phytomedicine; 2010 Feb; 17(2):94-9. PubMed ID: 19962288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EEG and video documentation of benzodiazepine challenge in catatonic stupor: A case report.
    Tamune H; Tsukioka Y; Sakuma S; Taira D; Takaoka Y; Tamura N; Kato T
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):468-473. PubMed ID: 38453164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study.
    Sarris J; Scholey A; Schweitzer I; Bousman C; Laporte E; Ng C; Murray G; Stough C
    Hum Psychopharmacol; 2012 May; 27(3):262-9. PubMed ID: 22311378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Schizophrenia With Catatonia Resistant to Lorazepam and Olanzapine Monotherapy But Responsive to Combination Treatment: Is It Time to Consider Using Select Second-Generation Antipsychotics Earlier in the Treatment Algorithm for This Patient Type?
    Spiegel DR; Glad R; Smith M; Raja U; Wade R; Johnson K
    Clin Neuropharmacol; 2019; 42(2):57-59. PubMed ID: 30762605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind cross-over clinical comparison of two 2'-chloro benzodiazepines: 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (chlordesmethyldiazepam) versus 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in neurotic anxiety.
    Andreoli V; Maffei F; Montanaro N; Morandini G
    Arzneimittelforschung; 1977 Feb; 27(2):436-9. PubMed ID: 16622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.